PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
86.64%
Revenue growth above 1.5x CVE's 8.26%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
224.24%
Positive gross profit growth while CVE is negative. John Neff would see a clear operational edge over the competitor.
23983.33%
Positive EBIT growth while CVE is negative. John Neff might see a substantial edge in operational management.
23983.33%
Positive operating income growth while CVE is negative. John Neff might view this as a competitive edge in operations.
2022.22%
Positive net income growth while CVE is negative. John Neff might see a big relative performance advantage.
1992.86%
Positive EPS growth while CVE is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
1992.86%
Positive diluted EPS growth while CVE is negative. John Neff might view this as a strong relative advantage in controlling dilution.
0.92%
Slight or no buybacks while CVE is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
No Data
No Data available this quarter, please select a different quarter.
-3.59%
Dividend reduction while CVE stands at 78.72%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-8.87%
Negative OCF growth while CVE is at 2.15%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-28.64%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-23.01%
Negative 10Y revenue/share CAGR while CVE stands at 26.62%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
168.71%
5Y revenue/share CAGR above 1.5x CVE's 63.87%. David Dodd would look for consistent product or market expansions fueling outperformance.
3.04%
3Y revenue/share CAGR under 50% of CVE's 97.71%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
-62.17%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
145.99%
Below 50% of CVE's 454.52%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
-2.73%
Negative 3Y OCF/share CAGR while CVE stands at 176.50%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
419.26%
Positive 10Y CAGR while CVE is negative. John Neff might see a substantial advantage in bottom-line trajectory.
425.81%
Positive 5Y CAGR while CVE is negative. John Neff might view this as a strong mid-term relative advantage.
-1.27%
Negative 3Y CAGR while CVE is 81.52%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
-82.36%
Both are negative. Martin Whitman suspects the segment is in decline or saddled with persistent unprofitability or write-downs.
-45.21%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
-49.93%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
-86.10%
Both reduced dividends long-term. Martin Whitman might check if sector-level headwinds forced universal cuts.
70.10%
Stable or rising mid-term dividends while CVE is cutting. John Neff sees an edge in consistent payouts vs. the competitor.
103.48%
Our short-term dividend growth is positive while CVE cut theirs. John Neff views it as a comparative advantage in shareholder returns.
-1.74%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
No Data
No Data available this quarter, please select a different quarter.
3.07%
Positive asset growth while CVE is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
32.42%
Positive BV/share change while CVE is negative. John Neff sees a clear edge over a competitor losing equity.
-0.22%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
3.79%
SG&A declining or stable vs. CVE's 126.58%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.